Biochemical and Histologic Study of Lethal Cisplatin Nephrotoxicity Prevention by Mirtazapine
Overview
Authors
Affiliations
Background: Cisplatin is a platinum derivative frequently used in the chemotherapy of different solid tumors. This biochemical and histologic study investigated a possible protective effect of mirtazapine with regard to cisplatin-induced nephrotoxicity in the rat.
Methods: The animals were divided into 4 groups: 15 mg/kg mirtazapine + 10 mg/kg cisplatin, 30 mg/kg mirtazapine + 10 mg/kg cisplatin, only 10 mg/kg cisplatin and negative control (healthy) group. During 14 days, the treatment and treated control group took drugs, while the healthy animals were given distilled water on the same schedule. All animals were sacrificed by high-dose anesthesia at the end of the 14 days of treatment; their kidneys were removed and subjected to histologic and biochemical study.
Results: In both of the doses we used, mirtazapine decreased the levels of malondialdehyde, creatinine, blood urea nitrogen and myeloperoxidase activity when compared to cisplatin group. On the other hand, it increased total glutathione level in all doses. Slight histopathological findings were determined in mirtazapine groups when compared to cisplatin control group.
Conclusion: In the light of our results and literature knowledge, we can conclude that the protective effect of mirtazapine in cisplatin toxicity originates from its own antioxidant activity.
Ndhlala A, Thibane V, Masehla C, Mokwala P Plants (Basel). 2022; 11(11).
PMID: 35684224 PMC: 9182599. DOI: 10.3390/plants11111451.
Drug Repositioning Using Temporal Trajectories of Accompanying Comorbidities in Diabetes Mellitus.
Park N, Jeon J, Jeong E, Kim S, Yoon D Endocrinol Metab (Seoul). 2022; 37(1):65-73.
PMID: 35144331 PMC: 8901955. DOI: 10.3803/EnM.2021.1275.
Casanova A, Harvat M, Vicente-Vicente L, Pellicer-Valero O, Morales A, Lopez-Hernandez F Antioxidants (Basel). 2021; 10(9).
PMID: 34572987 PMC: 8464812. DOI: 10.3390/antiox10091355.
Ciftci O, Onat E, Cetin A Iran J Pharm Res. 2018; 16(4):1424-1431.
PMID: 29552051 PMC: 5843304.
Ueda J, Yoshida H, Makino H, Maruyama H, Yokoyama T, Hirakata A Clin J Gastroenterol. 2017; 10(5):420-425.
PMID: 28776316 DOI: 10.1007/s12328-017-0767-7.